# RDF export of group: Publication
<http://ctro/data#Publication_21282> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_21282> <http://www.w3.org/2000/01/rdf-schema#label> "Publication 21282" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasTitle> "Safety and efficacy of linagliptin as add - on therapy to metformin in patients with type 2 diabetes : a randomized , double - blind , placebo - controlled study ." .
<http://ctro/data#Publication_21282> <http://ctro/data#hasAuthor> "Taskinen MR" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasPublicationYear> "2011" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasJournal> "Diabetes Obes Metab" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasPMID> "21114605" .
<http://ctro/data#Publication_21282> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_21289> .
<http://ctro/data#Publication_21282> <http://ctro/data#hasAuthor> "Rosenstock J" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasAuthor> "Tamminen I" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasAuthor> "Kubiak R" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasAuthor> "Patel S" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasAuthor> "Dugi KA" .
<http://ctro/data#Publication_21282> <http://ctro/data#hasAuthor> "Woerle HJ" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_21289> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_21289> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial 21289" .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasObjectiveDescription> "To evaluate the efficacy and safety of the potent and selective dipeptidyl peptidase - 4 ( DPP - 4 ) inhibitor linagliptin administered as add - on therapy to metformin in patients with type 2 diabetes with inadequate glycaemic control ." .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasCTduration> "24 - week" .
<http://ctro/data#AllocationRatio_21293> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#CTAnalysisApproach_21294> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasConclusionComment> "The addition of linagliptin 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin resulted in a significant and clinically meaningful improvement in glycaemic control without weight gain or increased risk of hypoglycaemia ." .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasArm> <http://ctro/data#Arm_21331> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasPopulation> <http://ctro/data#Population_21305> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_21579> .
<http://ctro/data#EvidenceQuality_21301> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasArm> <http://ctro/data#Arm_21340> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_21588> .
<http://ctro/data#ClinicalTrial_21289> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_21597> .
# RDF export of group: Population
<http://ctro/data#Population_21305> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_21305> <http://www.w3.org/2000/01/rdf-schema#label> "Population 21305" .
<http://ctro/data#Population_21305> <http://ctro/data#hasPrecondition> "inadequate glycaemic control" .
<http://ctro/data#Ethnicity_21307> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Country_21308> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country> .
<http://ctro/data#Gender_21312> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
<http://ctro/data#Population_21305> <http://ctro/data#hasPrecondition> "HbA1c levels of 7 . 0 - 10 . 0 % on metformin and a maximum of one additional antidiabetes medication" .
<http://ctro/data#Population_21305> <http://ctro/data#hasPrecondition> "inadequately controlled on metformin" .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_21402> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_21402> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#Endpoint_21402> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#Mean_21404> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_21402> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_21404> .
<http://ctro/data#Endpoint_21402> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_21406> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_21407> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_21407> <http://www.w3.org/2000/01/rdf-schema#label> "fpg" .
<http://ctro/data#Endpoint_21407> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingBloodGlucose> .
<http://ctro/data#AggregationMethod_21409> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_21407> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre> .
<http://ctro/data#MeasurementDevice_21411> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_21520> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_21520> <http://www.w3.org/2000/01/rdf-schema#label> "ppg" .
<http://ctro/data#Endpoint_21520> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialPlasmaGlucose> .
<http://ctro/data#AggregationMethod_21522> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_21520> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre> .
<http://ctro/data#MeasurementDevice_21524> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_21606> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_21606> <http://www.w3.org/2000/01/rdf-schema#label> "hyp" .
<http://ctro/data#Endpoint_21606> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia> .
<http://ctro/data#AggregationMethod_21608> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_21609> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_21610> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_21665> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_21665> <http://www.w3.org/2000/01/rdf-schema#label> "wei" .
<http://ctro/data#Endpoint_21665> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight> .
<http://ctro/data#AggregationMethod_21667> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_21665> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg> .
<http://ctro/data#MeasurementDevice_21669> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_21331> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_21331> <http://www.w3.org/2000/01/rdf-schema#label> "lin" .
<http://ctro/data#Arm_21331> <http://ctro/data#hasNumberPatientsArm> "524" .
<http://ctro/data#Arm_21331> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_21349> .
<http://ctro/data#Arm_21331> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21412> .
<http://ctro/data#Arm_21331> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_21611> .
<http://ctro/data#Arm_21331> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_21387> .
<http://ctro/data#Arm_21331> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21466> .
<http://ctro/data#Arm_21331> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21525> .
<http://ctro/data#Arm_21331> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21670> .
<http://ctro/data#Arm_21340> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_21340> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Arm_21340> <http://ctro/data#hasNumberPatientsArm> "177" .
<http://ctro/data#Arm_21340> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_21355> .
<http://ctro/data#Arm_21340> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21439> .
<http://ctro/data#Arm_21340> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_21638> .
<http://ctro/data#Arm_21340> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_21387> .
<http://ctro/data#Arm_21340> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21493> .
<http://ctro/data#Arm_21340> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21552> .
<http://ctro/data#Arm_21340> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_21697> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_21349> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_21349> <http://www.w3.org/2000/01/rdf-schema#label> "lin" .
<http://ctro/data#Medication_21350> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Intervention_21349> <http://ctro/data#hasFrequency> "once daily" .
<http://ctro/data#RelativeTime_21354> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_21355> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_21355> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Intervention_21355> <http://ctro/data#hasMedication> <http://ctro/data#Medication_21368> .
<http://ctro/data#RelativeTime_21360> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_21387> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_21387> <http://www.w3.org/2000/01/rdf-schema#label> "met" .
<http://ctro/data#Intervention_21387> <http://ctro/data#hasMedication> <http://ctro/data#Medication_21393> .
<http://ctro/data#RelativeTime_21392> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_21361> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_21361> <http://www.w3.org/2000/01/rdf-schema#label> "lin" .
<http://ctro/data#Medication_21361> <http://ctro/data#hasDrug> <http://ctro/data#Linagliptin> .
<http://ctro/data#Medication_21361> <http://ctro/data#hasDoseValue> "5 mg" .
<http://ctro/data#BioAndMedicalUnit_21364> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_21365> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_21368> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_21368> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Medication_21368> <http://ctro/data#hasDrug> <http://ctro/data#Placebo> .
<http://ctro/data#BioAndMedicalUnit_21371> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_21372> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_21393> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_21393> <http://www.w3.org/2000/01/rdf-schema#label> "met" .
<http://ctro/data#Medication_21393> <http://ctro/data#hasDrug> <http://ctro/data#Metformin> .
<http://ctro/data#Medication_21393> <http://ctro/data#hasDoseValue> "≥ 1500 mg / day" .
<http://ctro/data#BioAndMedicalUnit_21396> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_21397> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_21412> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21412> <http://www.w3.org/2000/01/rdf-schema#label> "hba lin" .
<http://ctro/data#Outcome_21412> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21402> .
<http://ctro/data#Outcome_21412> <http://ctro/data#hasBaselineValue> "8 . 1" .
<http://ctro/data#Outcome_21412> <http://ctro/data#hasChangeValue> "- 0 . 49" .
<http://ctro/data#Outcome_21439> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21439> <http://www.w3.org/2000/01/rdf-schema#label> "hba pla" .
<http://ctro/data#Outcome_21439> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21402> .
<http://ctro/data#Outcome_21439> <http://ctro/data#hasBaselineValue> "8 . 1" .
<http://ctro/data#Outcome_21439> <http://ctro/data#hasChangeValue> "0 . 15" .
<http://ctro/data#Outcome_21466> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21466> <http://www.w3.org/2000/01/rdf-schema#label> "fpg lin" .
<http://ctro/data#Outcome_21466> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21407> .
<http://ctro/data#Outcome_21466> <http://ctro/data#hasBaselineValue> "9 . 4" .
<http://ctro/data#Outcome_21466> <http://ctro/data#hasChangeValue> "- 0 . 59" .
<http://ctro/data#Outcome_21493> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21493> <http://www.w3.org/2000/01/rdf-schema#label> "fpg pla" .
<http://ctro/data#Outcome_21493> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21407> .
<http://ctro/data#Outcome_21493> <http://ctro/data#hasBaselineValue> "9 . 4" .
<http://ctro/data#Outcome_21493> <http://ctro/data#hasChangeValue> "0 . 58" .
<http://ctro/data#Outcome_21525> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21525> <http://www.w3.org/2000/01/rdf-schema#label> "ppg lin" .
<http://ctro/data#Outcome_21525> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21520> .
<http://ctro/data#Outcome_21525> <http://ctro/data#hasChangeValue> "- 2 . 7" .
<http://ctro/data#Outcome_21552> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21552> <http://www.w3.org/2000/01/rdf-schema#label> "ppg pla" .
<http://ctro/data#Outcome_21552> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21520> .
<http://ctro/data#Outcome_21552> <http://ctro/data#hasChangeValue> "1 . 0" .
<http://ctro/data#Outcome_21611> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21611> <http://www.w3.org/2000/01/rdf-schema#label> "hyp lin" .
<http://ctro/data#Outcome_21611> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21606> .
<http://ctro/data#Outcome_21611> <http://ctro/data#hasNumberAffected> "three" .
<http://ctro/data#Outcome_21611> <http://ctro/data#hasPercentageAffected> "0 . 6" .
<http://ctro/data#Outcome_21638> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21638> <http://www.w3.org/2000/01/rdf-schema#label> "hyp pla" .
<http://ctro/data#Outcome_21638> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21606> .
<http://ctro/data#Outcome_21638> <http://ctro/data#hasNumberAffected> "five" .
<http://ctro/data#Outcome_21638> <http://ctro/data#hasPercentageAffected> "2 . 8" .
<http://ctro/data#Outcome_21670> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21670> <http://www.w3.org/2000/01/rdf-schema#label> "wei lin" .
<http://ctro/data#Outcome_21670> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21665> .
<http://ctro/data#Outcome_21670> <http://ctro/data#hasChangeValue> "- 0 . 5" .
<http://ctro/data#Outcome_21697> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_21697> <http://www.w3.org/2000/01/rdf-schema#label> "wei pla" .
<http://ctro/data#Outcome_21697> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_21665> .
<http://ctro/data#Outcome_21697> <http://ctro/data#hasChangeValue> "- 0 . 4" .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_21579> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_21579> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#DiffBetweenGroups_21579> <http://ctro/data#hasPvalueDiff> "p < 0 . 0001" .
<http://ctro/data#DiffBetweenGroups_21579> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_21412> .
<http://ctro/data#DiffBetweenGroups_21579> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_21439> .
<http://ctro/data#DiffBetweenGroups_21588> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_21588> <http://www.w3.org/2000/01/rdf-schema#label> "fpg" .
<http://ctro/data#DiffBetweenGroups_21588> <http://ctro/data#hasPvalueDiff> "p < 0 . 0001" .
<http://ctro/data#DiffBetweenGroups_21588> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_21466> .
<http://ctro/data#DiffBetweenGroups_21588> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_21493> .
<http://ctro/data#DiffBetweenGroups_21597> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_21597> <http://www.w3.org/2000/01/rdf-schema#label> "ppg" .
<http://ctro/data#DiffBetweenGroups_21597> <http://ctro/data#hasPvalueDiff> "p < 0 . 0001" .
<http://ctro/data#DiffBetweenGroups_21597> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_21525> .
<http://ctro/data#DiffBetweenGroups_21597> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_21552> .
# RDF export of group: EvidenceQuality